Skip to content
Back

Anna Kaufmann, MSc

Scientific Associate - currently on maternity leave

EB-Haus Forschungsmitarbeiterin

Contact

Research statement

I am interested in developing an immune therapy against aggressive squamos cell carcinoma, which many dystrophic epidermolysis bullosa patients are suffering from. I am always keen to learn new techniques that are relevant to translational research in genetic diseases

Personal interests

I am a passionate horse enthusiast and spend most of my free time with my horse and dogs.

Curriculum Vitae Anna Kaufmann

Professional Career

Since 2017
Scientific Associate
at the EB House Austria

05/2017-07/2017
Staff member of the laboratory for food control at Ennstal Milch KG

04/2016-06/2016
Scientific Associate at the EB House Austria

 

Education

2016
MSc
in Molecular Mircobiology, Graz University of Technology
"Double RNA trans-splicing induced gene repair in COL7A1"
Research group: Univ.-Prof. Dr. Johann Bauer, Dr. Ulrich Koller

2013
BSc
in Molecular Biology, Graz University of Technology
"Specific signal transduction cascades in the intrinsic pathway of apoptosis"
Research group: Univ.-Prof. Dr. Günther Koraimann

 

Awards and Fellowships

2014/2015 Performance Scholarship in academic year

 

Additional Qualifications/Training

2017 LAS course 2017, Paris Lodron Universität Salzburg

Original articles

  1. Welponer T, Weber DD, Trattner L, Tockner B, Aminzadeh-Gohari S, Leb-Reichl V, Kaufmann A, Zauner R, Wimmer M, Wally V, Felder TK, Strunk D, Koller U, Bauer JW, Kofler B, Guttmann-Gruber C, Piñon Hofbauer J. Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma. Journal of the European Academy of Dermatology and Venereology : JEADV 2023
  2. Woess K, Sun Y, Morio H, Stierschneider A, Kaufmann A, Hainzl S, Trattner L, Kocher T, Tockner B, Leb-Reichl V, Steiner M, Brachtl G, South AP, Bauer JW, Reichelt J, Furihata T, Wally V, Koller U, Piñón Hofbauer J, Guttmann-Gruber C. Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer. International journal of molecular sciences 2022;23.
  3. Hüttner C, Murauer EM, Hainzl S, Kocher T, Neumayer A, Reichelt J, Bauer JW, Koller U. Designing Efficient Double RNA trans-Splicing Molecules for Targeted RNA Repair. Int J Mol Sci 2016;17(10). pii: E1609.
Back to main navigation